Familial Hyperproinsulinemia
- 22 April 1976
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 294 (17) , 911-915
- https://doi.org/10.1056/nejm197604222941701
Abstract
We describe a genetic defect in a kindred in whom proinsulin or a proinsulin-like material constitutes the major fraction of circulating insulin immunoreactivity in both the fasting and stimulated states. The defect, familial hyperproinsulinemia, affects eight males and 10 females in four generations of the kindred, with an autosomal dominant mode of transmission. Familial hyperproinsulinemia is asymptomatic in the affected progeny, with no apparent relation to hypoglycemia or to the development of diabetes mellitus. This genetic defect may represent either a deficiency in the proinsulin cleaving enzyme (or enzymes) within the beta cell, or more probably, an abnormal species of proinsulin. (N Engl J Med 294:911–915, 1976)This publication has 4 references indexed in Scilit:
- Plasma Proinsulin in Patients with Functioning Pancreatic Islet Cell Tumors1Journal of Clinical Endocrinology & Metabolism, 1972
- Proinsulin Secretion by a Pancreatic Beta-Cell AdenomaNew England Journal of Medicine, 1970
- THE BIOSYNTHESIS OF INSULIN AND A PROBABLE PRECURSOR OF INSULIN BY A HUMAN ISLET CELL ADENOMAProceedings of the National Academy of Sciences, 1967
- Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic RatsDiabetes, 1963